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Abstract
Objectives
Positive affect (PA) plays a crucial role in the development, course, and recovery of depres-
sion. Recently, we showed that a therapeutic application of the experience sampling meth-
od (ESM), consisting of feedback focusing on PA in daily life, was associated with a
decrease in depressive symptoms. The present study investigated whether the experience
of PA increased during the course of this intervention.
Design
Multicentre parallel randomized controlled trial. An electronic random sequence generator
was used to allocate treatments.
Settings
University, two local mental health care institutions, one local hospital.
Participants
102 pharmacologically treated outpatients with a DSM-IV diagnosis of major depressive dis-
order, randomized over three treatment arms.
Intervention
Six weeks of ESM self-monitoring combined with weekly PA-focused feedback sessions
(experimental group); six weeks of ESM self-monitoring combined with six weekly sessions
without feedback (pseudo-experimental group); or treatment as usual (control group).
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Main outcome
The interaction between treatment allocation and time in predicting positive and negative af-
fect (NA) was investigated in multilevel regression models.
Results
102 patients were randomized (mean age 48.0, SD 10.2) of which 81 finished the entire
study protocol. All 102 patients were included in the analyses. The experimental group did
not show a significant larger increase in momentary PA during or shortly after the interven-
tion compared to the pseudo-experimental or control groups (χ2 (2) =0.33, p = .846). The
pseudo-experimental group showed a larger decrease in NA compared to the control group
(χ2 (1) =6.29, p = .012).
Conclusion
PA-focused feedback did not significantly impact daily life PA during or shortly after the in-
tervention. As the previously reported reduction in depressive symptoms associated with
the feedback unveiled itself only after weeks, it is conceivable that the effects on daily life
PA also evolve slowly and therefore were not captured by the experience sampling proce-
dure immediately after treatment.
Trial Registration
Trialregister.nl/trialreg/index.asp. NTR1974
Introduction
Research on the factor structure of human emotional responses has identified two different, yet
related, affective dimensions: Positive (PA) and negative affect (NA). The reward-oriented PA
dimension, reflecting affective states such as enthusiasm, cheerfulness, and contentment, is as-
sociated with behavioural approach or engagement with the environment; the threat-oriented
NA dimension, reflecting affective states such as anxiety, loneliness, and guilt, is associated
with behavioural avoidance or withdrawal [1, 2]. PA and NA seem to represent two separate di-
mensions, which are usually negatively correlated within a person [3].
Traditionally, depression has been linked to disturbances in NA regulation. Stress-sensitivi-
ty, as an example, has been intensively investigated as a prominent (risk-) factor in depression
[4]. Similarly, cognitive behavioural therapy traditionally focusses on negative thoughts and
the down-regulation of NA [5]. However, converging evidence suggests that particularly a defi-
ciency in PA, linked to the concept of anhedonia, represents a core mechanism underlying de-
pression [6]. Likewise, recent studies show that a high ability to experience PA, rather than
NA, is predictive for the development, course, and recovery of depression [7–11]. This finding
provides potential routes to novel treatments in depression, i.e., interventions aimed at increas-
ing positive affective experience in daily life [12].
Experience Sampling Methodology as Intervention
The Experience Sampling Method (ESM) is a structured diary technique requiring individuals
to repeatedly report their affective states and behaviour together with contextual information
Personalized Feedback on Positive Affect in Depression Using ESM
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in the flow of daily life [13–15]. ESM has until recently been mainly used to assess subjects for
research purposes. However, the replacement of paper-and-pencil based diaries by electronic
sampling devices introduces the possibility of rapid analysis and availability of real life experi-
ential data [16]. Electronically collected data thus can be used not only to monitor, but also to
give feedback to the patient and professional caregiver with minimal delay, providing fine-
grained, prospective information on affective patterns, behaviour and contextual influences in
daily life [17, 18]. Using ESM not merely as an instrument to monitor, but as a tool to intervene
(referred to as ESM-I), may be promising for the development of new mHealth (‘mobile
health’) therapies in depression [17–19].
The present study
The current randomized controlled trial (RCT) in a sample of depressed patients was designed
to evaluate an intervention aimed at reducing depressive symptoms by enhancing PA in daily
life using ESM-I. During the six-week intervention, self-collected ESM data on momentary af-
fective and behavioural responses was fed-back to the patient on a weekly basis. Given the po-
tentially pivotal role of PA in the recovery of depression, the feedback focused on positive
affective experience in daily life. The experimental feedback condition was compared to two
other conditions: a pseudo-experimental condition in which the weekly feedback sessions were
replaced by weekly meetings with the researcher without feedback, and a control condition
without any meetings with the researcher during the intervention period.
Recently, we reported the results of this RCT with respect to its effectiveness in reducing de-
pressive symptomatology [20]. It was demonstrated that the ESM-derived, PA-focused feed-
back was associated with a linear decrease in depressive symptoms in the six months following
the intervention, a pattern not observed in the other two conditions [20]. As such, the interven-
tion appeared to be effective in reducing depressive symptoms in the long run. However, the
question remains as to whether the intervention, aimed at increasing PA in daily life, was in-
deed associated with a boost of momentary positive affective experience. The purpose of the
present study is to shed light on the potential micro-mechanism by which PA-focused ESM-I
may lead to a decrease in depressive symptoms. It was hypothesized that the experimental feed-
back condition, compared to the pseudo-experimental and control condition, would be associ-
ated with an increase in PA (and an associated decrease in NA) during and shortly after
the intervention.
Methods
Ethics statement
The study was approved by the local ethics committee (Medical Ethics Committee of Maas-
tricht University Medical Centre, azM/UM, #NL26181.068.09/MEC09-03-013) and all partici-
pants provided written informed consent before their enrolment. The trial was registered at the
Netherlands Trial Register (Identifier: NTR1974). The study was performed according to the
declaration of Helsinki. The original protocol and a CONSORT checklist are provided (see S1
Protocol and S1 CONSORT Checklist).
Study Overview
The multicentre trial was conducted between January 2010 and October 2012 in the following
settings: Maastricht University, two local mental health care institutions, and a local hospital.
Participant recruitment took place between January 2010 and February 2012 in mental health
care institutions and through local advertisements.
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Participants were considered eligible when they were between 18 and 65 years of age; diag-
nosed with a depressive episode according to DSM-IV [21] with current or residual symptoms
(17-item Hamilton Depression Rating Scale (HDRS) score of>7); treated with antidepressants
or mood stabilizers; and in possession of sufficient Dutch language skills. Participants were ex-
cluded if they met criteria for a non-affective psychotic disorder according to DSM-IV or if
they reported a (hypo-) manic or mixed episode within the past month.
Procedure
The recruitment process started with a short telephone interview conducted by a psychologist
or psychiatrist to establish whether inclusion criteria were likely met. If so, potential partici-
pants were invited to a full screening on site. During the screening, the Structured Clinical In-
terview for DSM-IV Axis I Disorders (SCID-I) [21] and the HDRS [22] were administered. If
admitted to the study, the participants underwent a five-day ESM baseline assessment followed
by randomization to either the experimental group, pseudo-experimental group or control
group. Randomization with allocation ratio 1:1:1 was stratified with respect to duration of
pharmacological treatment (use of a particular antidepressant for shorter vs. longer than 8
weeks prior to study entry) and the attendance of psychotherapy (yes/no). Allocation took
place by drawing a sealed envelope (prepared by an independent research coordinator) with a
number sequence produced by an electronic random sequence generator (www.random.org)
in blocks of six. Due to the nature of the psychological treatment allocation was not blinded.
Participants allocated to the experimental group underwent a six-week ESM protocol con-
sisting of a three-day ESM assessment period per week and, in addition to their treatment as
usual (TAU), six weekly ESM-based feedback sessions (ESM-I). Participants allocated to the
pseudo-experimental group followed the same protocol, but instead of receiving ESM-based
feedback, this group engaged in a structured conversation with the researcher in the form of an
HDRS interview during the weekly sessions. The rationale for including the pseudo-experi-
mental group was to control for the potential effects of prolonged ESM-monitoring and weekly
appointments with the researcher on mood. During the six-week ESM protocol of the experi-
mental and pseudo-experimental groups, participants allocated to the control group received
TAU only. Finally, all participants underwent a five-day ESM period after the six-week inter-
vention period (hereafter: post-assessment).
In summary, all three groups underwent an ESM pre- and post-assessment. Based on previ-
ous work and conventions regarding experiencing sampling research in individuals with men-
tal illness [23, 24], the duration of the pre-and post-assessment was set to five consecutive days.
During the six-week intervention period, the experimental and pseudo-experimental groups
engaged in three days of ESM per week (i.e., three consecutive days instead of five days a week
in order to reduce the weekly burden imposed on the patients), combined with weekly feedback
sessions (experimental group) or weekly structured conversations without feedback (pseudo-
experimental group).
Experience Sampling Method
ESM is a validated, structured diary technique to assess participants in their daily living envi-
ronment. It is a momentary assessment method providing repeated in-the-moment micro-
measurements of affect and context in a prospective and ecologically valid manner [13, 14, 23].
Participants received a dedicated mHealth electronic ESM device (‘PsyMate’), emitting a
signal (‘beep’) at a random moment in each of ten 90-minute time blocks between 07:30 am
and 10:30 pm. The signal prompted participants to fill in self-assessments (7-point Likert scale
ratings and forced-choice questions) automatically shown on the device display. To minimize
Personalized Feedback on Positive Affect in Depression Using ESM
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memory distortion, participants were instructed to complete their reports immediately upon
the signal; after 10 minutes, the self-assessments were no longer available for completion. The
ESM procedure was explained in an initial briefing session and a practice run was performed to
ensure that the participants understood the questions and the device.
Intervention
The experimental group received standardized ESM-derived feedback. Feedback sessions im-
mediately followed the weekly ESM procedure. In these face-to-face sessions, feedback was
provided by a psychologist or psychiatrist. The feedback on participants’ momentary affective
states in specific daily life contexts and the association with depressive symptoms was given
graphically, presented by the researcher according to a standardized verbal protocol. A written
summary based on a standardized template was provided to the participant as well as the
attending clinician.
Feedback structure. Every feedback session consisted of two parts. In the first part, infor-
mation with respect to experiences during the most recent week was presented. In the second
part, this information was placed in the context of all previous weeks.
Feedback content. The feedback sessions consisted of information that was repeated each
week, as well as variable feedback elements. Each week, information regarding the degree and
distribution of PA experienced during the past week was presented, as well as graphs displaying
the course of experienced PA across the weeks. Furthermore, the course of depressive feelings
over the weeks was presented in each session and compared to the course of PA. The variable
elements in the feedback procedure were divided over three modules. The first two weeks fo-
cused on daily activities and PA experienced during particular activities. The third and fourth
week focused on daily events and PA associated with these events. The last two weeks focused
on social interaction and associated PA. Variable elements were presented as described above
for the fixed feedback information, focusing on the most recent week followed by longitudinal
information over the weeks.
Please see S1 Feedback for an example of the graphical feedback and how the feedback was
discussed with the participant (extract of the session).
Outcome Measures
Primary outcome measures were PA and NA, derived as follows. During the ESM assessments
as described above, participants rated their momentary mental states by rating adjectives (iden-
tical at every time point) on a 7-point Likert scale, ranging from 1 (not) to 7 (very). Using the
STATA command FACTOR, within-person factor analysis (principal component factors with
oblique rotation) performed on these items (centred per person and ESM-week), identified two
factors with an eigenvalue >1, accounting for 46% of the variance: positive affect and negative
affect (Cronbach’s α 0.74/0.54 respectively). Positive affect comprised the average of ratings on
‘cheerful’, ‘enthusiastic’, ‘relaxed’ and ‘satisfied’ (with factor loadings>.6); negative affect
comprised the average of ratings on ‘lonely’, ‘anxious’, ‘guilty’, and ‘suspicious’ (with factor
loadings>.5).
Statistical Analyses
The data set had a hierarchical structure, due to within-person clustering: repeated measure-
ments (level 1), nested within individuals (level 2). Observations within one participant are
more similar than those across participants. As nesting of data typically violates the assumption
of independent residuals, multilevel regression analysis was used that takes clustering into ac-
count [25]. All analyses were performed using STATA 12 [26].
Personalized Feedback on Positive Affect in Depression Using ESM
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In order to examine the effect of the feedback intervention on PA and NA, two sets of analy-
ses were conducted. In the first set, the effects of the feedback intervention on change in PA
and NA from pre- to post-assessment, relative to the two control groups, was examined. To
this end, linear multilevel regression analyses (STATA command XTMIXED) were conducted
to inspect the categorical by categorical interaction between treatment allocation (experimental
vs. pseudo-experimental vs. control group) and time (pre- vs. post-assessment) as fixed effects.
The multilevel models for PA and NA, fitted via restricted maximum likelihood, included a
random intercept for participant and a random slope for time. The post-estimation commands
MARGINS and TEST (providing Wald tests) were used to calculate and compare the effect of
time on affect in the different groups.
In the second set of analyses, the effect of the feedback intervention on affect during the in-
tervention period, relative to the pseudo-experimental group, was examined. As the control
group was not seen during the intervention period, this group is not included in this analysis.
Using multilevel regression analyses (STATA command XTMIXED) fitted via restricted maxi-
mum likelihood, the categorical by categorical interaction between treatment allocation (exper-
imental vs. pseudo-experimental) and time (in weeks since start of the intervention) as fixed
effects was examined; the model included a random intercept for participant and a random
slope for time (intervention week 1–6).
Power calculations using the STATA SAMPSI command were based on previous work [27],
and led to an initial sample size of 120 with a power of 84% to detect a 3-point difference in the
score on the 17-item Hamilton Depression Rating Scale (HDRS, [22]) [28, 29], the main out-
come as reported in the previous study [20]. However, because many participants were exclud-
ed, the inclusion rate was lower than expected. The eventual number of patients who
participated in the trial was 102.
Results
Participants
A total of 309 patients underwent an initial screening by telephone, of which 102 were allocated
at random to the experimental, pseudo-experimental or control groups (see Fig 1 for the partic-
ipant flow through the study). At screening, the groups showed some differences in clinical fea-
tures: Compared to the pseudo-experimental and control group, patients in the experimental
group more often used lithium and displayed lower HDRS scores (Table 1); these differences
were no longer significant at baseline (two weeks later, i.e., just before the start of the interven-
tion, see also [20]). There were significant differences in sociodemographic variables between
the groups at baseline (Table 1).
Of the 102 randomized patients, 81 finished the ESM protocol (i.e., completed the ESM
post-assessment). Treatment assignment was not associated with probability of finishing the
ESM study protocol (χ2 (2) = 1.49, p =. 47) and number of attended intervention sessions
did not differ between the experimental and pseudo-experimental groups (F (1, 68) = 1.66,
p =. 20).
Previous work has shown that ESM assessments with less than 30% of filled out beeps are
less reliable and consequently not valid [14]. Therefore, ESM periods (one period correspond-
ing to one ESM ‘week’ in the protocol) with less than 30% of beeps completed were excluded
from the analyses, leading to the exclusion of one baseline ESM period, four post ESM periods,
and two periods during the intervention period (Fig 1).
Personalized Feedback on Positive Affect in Depression Using ESM
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Fig 1. Participant flow diagram.Completer: Participant who attended all six intervention sessions; Partial Completer: Participant who attended less than six
intervention sessions but did not withdrew from the study; non-completer: Participant who attended less than six intervention sessions and withdrew from
the study.
doi:10.1371/journal.pone.0128095.g001
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ESMmeasures and experimental sessions
Participants completed 16,678 device entries in total. Of these, 83 observations (<1%) were ex-
cluded as invalid because less than 30% of beeps for that ESM period were filled in. On average,
participants responded to 39.7 (out of maximal 50) beeps during the 5-day ESM periods (pre-and
post- assessment) and to 23.7 (out of maximal 30) during the 3-day periods (intervention). Fig 2
shows the individual PA series across the study protocol for one participant of each condition.
Feedback sessions lasted on average 48.9 minutes (SD 11.2, range 27–105 minutes), which
was significantly longer (b = 9.57, p<.001) than the duration of pseudo-experimental interview
sessions (mean: 39.5, SD 12.9, range 15–90 minutes).
Pre-post change in positive affect (χ2(3) = 0.48, p =. 923) or negative affect (χ2(3) = 0.57,
p =. 904) was not associated with the person who conducted the assessment or delivered the
(pseudo-) intervention.
Effects of the intervention on positive and negative affect from pre- to
post-assessment
Positive affect. The mean for positive affect increased by 0.3 points in the experimental
group, by 0.1 points in the pseudo-experimental group, and in the control group by 0.2 points
Table 1. Sample characteristics.
Experimental Group Pseudo-experimental Group Control Group Total
N 33 36 33 102
Age (SD) 48.7 (10.2) 46.7 (9.6) 48.9 (10.9) 48.0 (10.2)
Sex (M/F) 17/16 14/22 15/18 46/56
Education
Low (%) 6 (18.2) 9 (25.0) 10 (30.3) 24.5)
Middle (%) 12 (36.4) 14 (38.9) 12 (36.4) 38 (37.3)
High (%) 15 (45.5) 13 (36.1) 11 (33.3) 39 (38.2)
Full/ part time work (%) 13 (39.4) 10 (27.8) 12 (36.4) 35 (34.3)
Married (%) 12 (36.4) 16 (44.4) 17(51.5) 45 (44.1)
PA pre-assessment (SD) 3.4 (1.3) 3.3 (1.3) 3.2 (1.0) 3.3 (1.2)
PA post-assessment 3.7 (1.3) 3.4 (1.4) 3.4 (1.8) 3.5 (1.3)
NA pre-assessment (SD) 2.2 (1.1) 2.2 (1.2) 2.3 (1.2) 2.3 (1.2)
NA post-assessment 2.1 (1.4) 2.1 (1.2) 2.3 (1.3) 2.2 (1.3)
Current psychotherapy 4 (14.8) 4 (13.3) 2 (7.4) 10 (11.76)
Use of antidepressantsa
Maintenance (%) 28 (84.9) 30 (83.3) 25 (75.8) 83 (81.4)
Acute phase (%) 5 (15.2) 6 (16.7) 8 (24.2) 19 (18.6)
HDRS Mean (SD)b 14.1 (4.5) 16.2 (4.8) 17.0 (4.3) 15.8 (4.6)
Depressive episodec
Current (%) 19 (57.6) 24 (66.7) 25 (75.8) 68 (66.7)
In past (%) 14 (42.4) 12 (33.3) 8 (24.2) 34 (33.3)
Bipolar disorder 5 (15.2) 2 (5.6) 2 (6.1) 9 (8.8)
Use of lithium (%)d 7 (21.2) 1 (2.8) 3 (9.1) 11 (10.8)
a Maintenance = use of the antidepressant for  8 weeks; new = use of antidepressant < 8 weeks
b HDRS (Hamilton Depression Rating Scale) score significantly different between groups at screening (F = 3.64; p =. 03)
c According to SCID (Structured Clinical Interview for DSM-IV-TR Axis I disorders)
d Use of lithium at screening significantly different between the groups (χ2 = 6.23, Fisher’s exact p =. 049)
doi:10.1371/journal.pone.0128095.t001
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(see Table 1). Although the experimental group showed the largest increase in PA at mean
level, there was no significant interaction between group (experimental, pseudo-experimental,
control group) and time (pre- vs. post-assessment) (χ2(2) = 0.33, p =. 846)(Table 2).
Negative affect. Table 2 shows the detailed results of the mixed effects model. In contrast
to PA, there was a significant interaction between group (experimental, pseudo-experimental,
and control group) and time (pre- vs. post-assessment) (χ2(2) = 6.29, p =. 043). Adjusted pre-
dictions showed that the control group was associated with an increase of NA from 2.28 to
2.47; the pseudo-experimental group was associated with a decrease of NA from 2.21 to 1.99;
the experimental group was associated with a decrease of NA from 2.26 to 2.22. The slopes be-
tween the pseudo-experimental group and control group differed significantly (b = -0.40,
χ2(1) = 6.29, p =. 012), denoting that while the pseudo-experimental group decreased in NA by
0.19 points on a scale from 1 to 7, the control group increased by 0.21 points. There was no sig-
nificant difference in slopes between participants in the pseudo-experimental group and the
Fig 2. Individual PA series across the study protocol for three participants either randomized into the experimental (subject A), pseudo-
experimental (subject B) or control group (subject C). Dots represent the average momentary ratings on the adjectives composing PA (cheerful,
enthusiastic, relaxed, satisfied) during one beep. One day comprises ten beeps; pre- and post-assessment comprises five days; the intervention period
comprises three days of ESMmonitoring per week.
doi:10.1371/journal.pone.0128095.g002
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experimental group (b = -0.22, χ2(1) = 1.17, p =. 279), or between participants in the experi-
mental group and the control group (b = -0.20, χ2(1) = 1.85, p =. 174).
Effects of the intervention on positive and negative affect over the course
of the intervention
Fig 3 shows box-whisker diagrams and means for PA over the course of the intervention period
for the experimental and pseudo-experimental group.
Statistical modelling yielded no significant interaction between treatment allocation and in-
tervention week (1 to 6) (χ2(5) = 0.24, p =. 999) for positive affect. Likewise, there was no signif-
icant interaction between treatment allocation and intervention week (1–6) for negative affect
(χ2(5) =. 50, p =. 992). See Table 3 for the detailed results of the mixed effects model.
Discussion
Building on evidence that PA may be a crucial system involved in phenotypic resilience in de-
pression [7, 12] and capitalizing on recent technical developments making electronically col-
lected ESM data readily available [17, 18], the present RCT focused on intervening at the level
of positive affective experience in daily life by providing PA-focused feedback derived from
self-collected ESM data (ESM-I). In an earlier analysis in the same sample, we showed that
ESM-I was associated with a clinically relevant reduction of depressive symptoms commencing
three weeks after the intervention [20]. In the present study, we zoomed in on the micro-level
of every-day positive and negative affective experiences during the intervention, possibly shed-
ding light on the mechanisms through which ESM-I may occasion a reduction in depressive
symptomatology at the macro-level. That is, it was investigated if the PA-focused ESM-I was
indeed associated with an increase in positive affective experience in daily life during and short-
ly after the intervention.
Multilevel regression analysis yielded no statistically significant differences in the change
from pre- to post-test for the three different conditions. Likewise, the analysis yielded no
Table 2. Results of mixed effects models: Change in affect from pre to post-assessment.
Variable Positive affect Negative affect
b (SE); [CI] b (CI); [CI]
Groupa
Pseudo-exp. 0.17 (0.22);[-0.26, 0.59] -0.07 (0.24); [-0.54, 0.39]
Exp. 0.21 (0.22); [-0.23, 0.64] -0.02 (0.24); [-0.49, 0.45]
Timeb 0.15 (0.16); [-0.16, 0.46] 0.19 (0.12); [-0.04, 0.43]
Group*Time
Pseudo-exp./post assessment -0.01 (0.21); [-0.43, 0.41] -0.41 (0.16); [-0.73, -0.09]c
Exp./post-assessment -0.11 (0.22); [-0.55, 0.33] -0.23 (0.17); [-0.56, 0.10]
Estimation (SE) Estimation (SE)
Random Effects
Intercept SD (Participant) 0.89 (0.06); [0.77, 1.03] 0.97 (0.07); [0.84, 1.12]
Slope SD (Time) 0.11 (0.01); [0.09, 0.13] 0.08 (0.01); [0.07, 0.10]
b = Regression coefficient; SE = Standard Error; SD = Standard Deviation; CI = Confidence Interval;
Pseudo-exp. = Pseudo-experimental group; Exp. = Experimental group
a Reference category: Control group
b Reference category: Pre-assessment
c p = 0.012
doi:10.1371/journal.pone.0128095.t002
Personalized Feedback on Positive Affect in Depression Using ESM
PLOSONE | DOI:10.1371/journal.pone.0128095 June 2, 2015 10 / 16
statistically significant differences in PA during the intervention period between the experi-
mental and pseudo-experimental group. An inspection of the random effects in the mixed ef-
fects model suggests rather large individual differences. As such, it may be the case that the
effect of the intervention on PA is highly individual specific. Alternatively, the nonsignificant
Fig 3. Part A: Box-Whisker plot of PA across the intervention period, by condition. The bottom and top of box indicate first (Q1) and third quartile (Q3),
the band indicates the median; whiskers represent upper and lower adjacent values (within Q3+1.5(Q3-Q1) and Q1-1.5(Q3-Q1), respectively. Part B: Means
per week across intervention period, by condition.
doi:10.1371/journal.pone.0128095.g003
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findings may relate to the period chosen during which ESMmonitoring took place. Based on
our previous report, the differences in depressive symptoms between the experimental group
and control group became apparent three weeks after completion of the intervention and the
differences grew stronger over time. However, ESM data on momentary PA was, due to patient
burden, only available in the period during- and shortly (one week) after the intervention. It is
possible that an increase in positive affective experience would only become visible after the
measurement window of one week post-intervention. According to the broaden-and-build the-
ory [30], experiencing PA may increase the focus of an individual, enabling him or her to pay
more attention to rewarding events and to augment engagement in PA evoking activities, lead-
ing to the experience of even more positive affect. It may be that the development of such an
emotional “upward spiral” may take some time to develop. The translation of receiving PA-fo-
cused feedback in the clinical setting to the actual exploration of PA-evoking activities in daily
life, and eventually being able to activate the “upward spiral” of positive emotions, is probably
a process of trial and error, which may take some time to evolve. It is possible that this process
occurred after our ESM sampling window and therefore a change in affect was not captured
(see also the limitations section). Alternatively, the question may arise if the ESM-based PA
and NA were measured too momentarily to actually be able to pick up differences. However,
this possibility seems unlikely as previous studies using similar designs and identical PA and
NA assessments were able to show changes in momentary PA after an intervention [7, 12, 31].
Finally, an alternative possibility is that an increase in momentary PA is not the mechanism be-
hind the observed reduction in depressive symptoms in the experimental group and that it is
necessary to search for alternative mechanisms. Promising future directions for this search
Table 3. Results of mixed effects models: Change in affect during intervention period.
Variable Positive affect Negative affect
b (SE); [CI] b (CI); [CI]
Groupa 0.14 (0.29), [-0.43, 0.70] 0.16 (0.27), [-0.36, 0.68]
Timeb
Week 2 0.10 (0.28); [-0.46, 0.65] >-0.01(0.26); [-0.51, 0.51]
Week 3 0.16 (0.28); [-0.39, 0.72] -0.04 (0.26); [-0.55, 0.47]
Week 4 0.20 (0.29); [-0.36, 0.76] -0.22 (0.26); [-0.73, 0.30]
Week 5 0.24 (0.29); [-0.33, 0.80] -0.04 (0.26); [-0.55, 0.48]
Week 6 0.21(0.29); [-0.35, 0.78] -0.23 (0.27); [-0.75, 0.28]
Group*Time
Exp./week 2 0.03 (0.41); [-0.78, 0.84] -0.14 (0.38); [-0.88, 0.60]
Exp./week 3 0.13 (0.42); [-0.68, 0.95] -0.14 (0.38); [-0.89, 0.60]
Exp./week 4 0.09 (0.42); [-0.73, 0.91] -0.04 (0.38); [-0.79, 0.71]
Exp./week 5 0.12 (0.42); [-0.71, 0.94] -0.24 (0.39); [-0.10, 0.51]
Exp./week 6 0.17 (0.42); [-0.66, 1.00] -0.08 (0.39); [-0.84, 0.68]
Estimation (SE) Estimation (SE)
Random Effects
Slope SD (Week)c 1.17 (0.04); [1.09, 1.26] 1.08 (0.04); [1.01, 1.16]
b = Regression coefficient; SE = Standard Error; SD = Standard Deviation; CI = Confidence Interval;
Pseudo-exp. = Pseudo-experimental group; Exp. = Experimental group
a Reference category: Pseudo-experimental group
b Reference category: Week 1
c Intercept (subject) suppressed
doi:10.1371/journal.pone.0128095.t003
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include investigating the temporal dynamics of affect (i.e. variability/temporal dependency)
and conducting within-person mediation analyses using multilevel path analyses.
While the results indicated no significant change in NA levels in the experimental group
during the intervention period, participants in the pseudo-experimental group showed a stron-
ger decrease in NA from pre- to post-assessment compared to the control group. This is in line
with our preceding paper, demonstrating that the pseudo-experimental group showed a reduc-
tion in depressive symptoms directly during the intervention period; however, this effect was
not persistent as depressive symptoms in the pseudo-experimental group started to increase
again during the follow-up period [20]. The decrease in NA may reflect a non-specific placebo
response as patients may have thought that they were receiving the experimental intervention.
Alternatively, the sessions with the researcher, during which the patient was able to talk about
his or her depressive feelings during the previous week, may have resulted in the specific reduc-
tion of NA. Instead, it may be that merely the monitoring of affective responses, behaviour and
context in daily life for the duration of six weeks may be associated with increased momentary
emotional awareness, making ESM interesting for use in mindfulness-based therapies [32].
Limitations
The present RCT did not include a fourth treatment arm, that is, a pseudo-experimental group
consisting of a six-week period of ESM self-monitoring only, without weekly contacts with the
researcher. Therefore, it was not possible to separate the effect of self-monitoring from the ef-
fects of weekly contacts with the researcher. This treatment arm was not included since the pri-
mary goal of the present RCT was to investigate the effects of feedback based on ESM, and not
the effects of ESM self-monitoring per se.
ESM was only performed over the course of the intervention and not during the 6-month
follow-up periods. As such, data with respect to daily life momentary PA and NA were only
available for the duration of the intervention period and the moments immediate before and
after. In light of our previous results with regard to the effects of ESM-I on depressive symp-
toms, showing that the effect of ESM-I may take some weeks to evolve, it would have been in-
structive to also have ESM data available in the weeks after completion of the intervention.
This would potentially have shed more light on the micro-mechanisms by which ESM-I did re-
duce depressive symptoms in the long term. It is a challenge for future ESM studies to identify
the ideal time frames for ESM monitoring in order to fully investigate the mechanisms of inter-
ventions at the micro-level while minimizing patient burden.
Finally, a considerably high number of patients who were initially contacted declined to par-
ticipate in this rather demanding trial. As such, it is possible that the present patient population
presented with certain (unassessed) patient characteristics.
Conclusion
In the present trial, we showed that a novel intervention based on ESM (referred to as ESM-I),
consisting of weekly feedback on the experience of PA in daily life, did not significantly impact
momentary PA during or shortly after the intervention. This finding contrasted with previous
results in this sample, demonstrating that the PA-focused ESM-I was associated with a decrease
in depressive symptoms on the long-term. As this reduction in depressive symptoms only un-
veiled itself after weeks, it is conceivable that the effects of the feedback on momentary PA also
evolved slowly and therefore were not captured by the experience sampling procedure during
and immediately after treatment. In light of these findings, an extension of the ESMmeasure-
ment window to follow-up measures when evaluating ESM-I, is recommended. Furthermore,
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given these inconsistent findings and novelty of ESM-I, additional studies are needed to estab-
lish effectiveness and optimal ESM-I content.
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